Artera, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced new data at ASCO GU 2023 demonstrating that its multimodal artificial intelligence...
Gilead Sciences, Inc. announced new and updated positive results from three cohorts of the Phase 2 TROPHY-U-01 study of Trodelvy for the treatment of...
Bristol Myers Squibb announced three-year follow-up results from the Phase 3 CheckMate -274 trial, demonstrating significant sustained clinical benefits with Opdivo (nivolumab) for the adjuvant...
Michelson Philanthropies and AAAS/Science award Dr. Aleksandar Obradovic,of the Department of Systems Biology at Columbia University Irving Medical Center, with the 2023 Michelson Philanthropies & Science Prize for Immunology....
Ligand Pharmaceuticals Incorporated announced that its partner Travere Therapeutics, Inc. has received accelerated approval from the U.S. Food and Drug Administration for FILSPARI to...
